Funding world-class research

Help us continue to find and fund the research that matters most to people living with leukaemia.
apple pay google pay paypal visa mastercard

Together we can stop leukaemia devastating lives.

Every year, around 10,000 people are newly diagnosed with leukaemia in the UK. And nearly 5,000 lives continue to be lost each year. Further research is urgently needed to develop kinder and more effective treatments for this devastating disease.

By donating to Leukaemia UK you will be helping us to find and fund the research that matters most to the people whose lives are impacted by leukaemia – targeting the areas where progress is most urgently needed.

How would you like to support our vital work?

Donate in memory
donate in memory

Donate in memory

Leave a gift in your will
Photo of a gift being given

Leave a gift in your will

Donate through your salary
Woman using laptop

Donate through your salary

Donate while you shop
open sign on shop door

Donate while you shop

Volunteer for us

Volunteer for us

Corporate fundraising

Partner with us

How are your donations used?

Your donations will help fund research into both acute and chronic leukaemia, lymphoma and other blood cancers.

You will be helping to improve early diagnosis, develop kinder and more effective treatments – and fund innovative trials. You will enable some of the best scientists and researchers to discover the latest breakthroughs in leukaemia treatment. You will be an essential part of the research team.

Ultimately these breakthroughs will mean that treatments will be kinder and more effective. That more children will survive childhood leukaemia and more grandparents will have longer with their families.

Find out more


could help develop kinder treatments for Acute Myeloid Leukaemia (AML), by targeting just the cancer cells and leaving the healthy cells intact.


could help investigate how T cells develop in Acute Lymphoblastic Leukaemia (ALL), leading to more personalised treatments.


could help understand the genetic differences in Acute Lymphoblastic Leukaemia (ALL) in different age groups to improve treatments.